𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

✍ Scribed by Hiroko Yamashita, Mariko Nishio, Tatsuya Toyama, Hiroshi Sugiura…

Book ID
120701228
Publisher
BioMed Central
Year
2003
Tongue
English
Weight
190 KB
Volume
6
Category
Article
ISSN
1465-5411

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abnormal expression of four novel molecu
Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein
✍ Han, Sehwan; Yun, Ik-Jin; Noh, Dong-Young; Choe, Kuk-Jin; Song, Sang-Yong; Chi, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

## Background: In view of the cumulative results to date, p53, nm23, erbb-2, and cathepsin d are the most promising investigational prognostic factors in breast cancer. ## Objectives: The clinical utility of these molecular markers to predict recurrence was evaluated. ## Methods: Archival patho

Loss of FHIT protein expression is a mar
Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer
✍ Christophe Ginestier; Valérie-Jeanne Bardou; Cornel Popovici; Emmanuelle Charafe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 225 KB

## Abstract The __FHIT__ tumor suppressor gene, which encompasses the fragile site __FRA3B__ at 3p14.2, is altered frequently in many types of human cancers. To determine its importance as a prognostic marker in breast cancer, the expression of the FHIT protein was studied in a series of 452 breast